1、J A N U A R Y 2 0 1 3 P o l i c Y B R i e fRenewing the Project BioShield ActWhat Has It Bought and Wrought?By Robert KadlecIn the next several months,the president and members of Congress will decide whether to continue the funding and authorities associated with Project BioShield,which seeks to ex
2、pand the U.S.stockpile of medical countermeasures for potential chemical,biological,radiological and nuclear(CBRN)attacks.Congress established Project BioShield in 2004 and provided it with 10 years of guaranteed funding.Two years later,it created the Biomedical Advanced Research and Development Aut
3、hority(BARDA)to oversee BioShields advanced development and procurement efforts.To date,BioShield has developed and procured more than 50 million doses of vaccines and drugs against several CBRN threats,and its investments have provided ancillary benefits as well.Renewing Project BioShield funding a
4、nd authorities would enable continued research,development and procurement of many promising treatments,which could prove critical if the United States were ever attacked with CBRN weapons.IntroductionWhen President George W.Bush signed the Project BioShield Act on July 2,2004,he declared that it wo
升级VIP 